References
- Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B (2006). Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr, 84, 18-28.
- Boyce SP, Mincey BA, Duh M, et al (2005). Risk of osteoporosis/osteopenia among women with breast cancer receivin anticancer theapy (ACT). J Clin Oncol, 23, 665. https://doi.org/10.1200/JCO.2005.09.922
- Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA (2011). Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the US Preventive Services Task Force. Ann Intern Med, 155, 827-38. https://doi.org/10.7326/0003-4819-155-12-201112200-00005
- Deeb KK, Trump DL, Johnson CS (2007). Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer, 7, 684-700. https://doi.org/10.1038/nrc2196
- Eastell R, Adams JE, Coleman RE, et al (2008). Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230. J Clin Oncol, 26, 1051-7. https://doi.org/10.1200/JCO.2007.11.0726
- Fakih MG, Trump DL, Johnson CS, et al (2009). Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. Int J Colorectal Dis, 24, 219-24. https://doi.org/10.1007/s00384-008-0593-y
- Feskanich D, Ma J, Fuchs CS, et al (2004). Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev, 13, 1502-8.
- Garland CF, Garland FC, Gorham ED, et al (2006). The role of vitamin D in cancer prevention. Am J Public Health, 96, 252-61. https://doi.org/10.2105/AJPH.2004.045260
- Giovannucci E, Liu Y, Rimm EB, et al (2006). Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst, 98, 451-9. https://doi.org/10.1093/jnci/djj101
- Gorham ED, Garland CF, Garland FC, et al (2005). Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol, 97, 179-94. https://doi.org/10.1016/j.jsbmb.2005.06.018
- Gorham ED, Garland CF, Garland FC, et al (2007). Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med, 32, 210-6. https://doi.org/10.1016/j.amepre.2006.11.004
- Hershberger PA, Yu WD, Modzelewski RA, et al (2001). Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis. Clin Cancer Res, 7, 1043-51.
- Holick MF (2007). Vitamin D deficiency. N Engl J Med, 357, 266-81. https://doi.org/10.1056/NEJMra070553
- Jenab M, Bueno-de-Mesquita HB, Ferrari P, et al (2010). Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ, 340, 5500. https://doi.org/10.1136/bmj.b5500
- Kanis JA (1994). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int, 4, 368-81. https://doi.org/10.1007/BF01622200
- Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008). FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int, 19, 385-97. https://doi.org/10.1007/s00198-007-0543-5
- Lee JE, Li H, Chan AT, et al (2011). Circulating levels of vitamin D and colon and rectal cancer: the Physicians’ Health Study and a meta-analysis of prospective studies. Cancer Prev Res, 4, 735-43. https://doi.org/10.1158/1940-6207.CAPR-10-0289
- Lonning PE, Geisler J, Krag LE, et al (2005). Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer. J Clin Oncol, 23, 5126-37. https://doi.org/10.1200/JCO.2005.07.097
- Ma Y, Yu WD, Hershberger PA, et al (2008). 1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model. Mol Cancer Ther, 7, 3047-55. https://doi.org/10.1158/1535-7163.MCT-08-0243
- Ma Y, Zhang P, Wang F, et al (2011). Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol, 29, 3775-82. https://doi.org/10.1200/JCO.2011.35.7566
- Maddipatla S, Tan W, Wilding GE, et al (2007). Vitamin D status in patients with colorectal cancer. 2007 Gastrointestinal Cancers Symposium Abstract 260.
- Moffatt KA, Johannes WU, Miller GJ (1999). 1Alpha, 25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines. Clin Cancer Res, 5, 695-703.
- Ng K, Meyerhardt JA, Wu K, et al (2008). Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol, 26, 2984-91. https://doi.org/10.1200/JCO.2007.15.1027
- Ng K, Sargent DJ, Goldberg RM, et al (2011). Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. J Clin Oncol, 29, 1599-606. https://doi.org/10.1200/JCO.2010.31.7255
- Ng K, Wolpin BM, Meyerhardt JA, et al (2009). Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br J Cancer, 101, 916-23. https://doi.org/10.1038/sj.bjc.6605262
- Perez EA, Josse RG, Pritchard KI, et al (2006). Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17. J Clin Oncol, 24, 3629-35. https://doi.org/10.1200/JCO.2005.05.4882
- Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. https://doi.org/10.3322/caac.21166
- Siegel R, Ward E, Brawley O, Jemal A (2011). Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin, 61, 212-36. https://doi.org/10.3322/caac.20121
- Trump DL, Deeb KK, Johnson CS (2010). Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy. Cancer J, 16, 1-9. https://doi.org/10.1097/PPO.0b013e3181c51ee6
- Wu K, Feskanich D, Fuchs CS, et al (2007). A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst, 99, 1120-9. https://doi.org/10.1093/jnci/djm038